(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...
AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...
For patients with acute ischemic stroke due to a large-vessel occlusion (LVO), administering intra-arterial thrombolytics after successful endovascular thrombectomy does not significantly improve ...
Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...
MBG and STR were significantly improved in the thrombus aspiration group. In addition, manual thrombectomy was associated with a lower incidence of cardiac death and nonfatal re-infarction at 1 year.
Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system. The FDA investigational device exemption (IDE) trial evaluates the safety ...
Background Performing mechanical thrombectomy (MT) in patients with basilar artery occlusion (BAO) is currently not evidence-based. Objective To compare patients’ outcome, relative merits of achieving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback